RegenerOss Resorbable XenograftRecalls & reported problems across all models
Collagen Matrix, Inc. · 2 models in the FDA device registry
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls
- 1
We found 2 models of RegenerOss Resorbable Xenograft by Collagen Matrix, Inc. in the FDA's device registry (GUDID). Together they are named in 3 adverse event reports in the FDA's MAUDE database, received between Sep 23, 2019 and Oct 18, 2019 — classified as 3 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).
1 FDA recall record name at least one of these models by its device identifier.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
RegenerOss Resorbable Xenograft recalls
FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.
- Oct 30, 2018Terminated
There is a possibility that the product labeled as 4.0cc volume may only contain 2.0cc volume and is therefore mislabeled.
Z-0752-2019 · Root cause: Employee error · Recall details · FDA record ↗
Most reported RegenerOss Resorbable Xenograft problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Insufficient Device Problem Information1
Patient problems
- Inadequate Osseointegration2
- Inflammation1
- No Code Available1
RegenerOss Resorbable Xenograft models
2 models, most reported first. Each model has its own page with its reports, recalls and device details.
- RegenerOss Resorbable Xenograft ROXR40Bone Grafting Material, Animal Source1 recall1 report
- RegenerOss Resorbable Xenograft ROXR05Bone Grafting Material, Animal Source2 reports
Recent RegenerOss Resorbable Xenograft adverse event reports
The 3 most recent reports across all models, in the reporter's own words as published by the FDA.
InjuryOct 18, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A CLINICIAN USED THE PORCINE XENOGRAFT ALONG WITH PUROS PARTICULATE ALLOGRAFT AND A BIOMEND ABSORBABLE COLLAGEN MEMBRANE. THE PATIENT RETURNED AFTER 5 MONTHS FOR IMPLANT PLACEMENT. THE CLINICIAN REPORTED TO BE UNHAPPY WITH THE OUTCOME OF THE BONE AUGMENTATION AND THE IMPLANT WAS UNABLE TO BE PLACED.
Patient problems: Inadequate Osseointegration
MAUDE report 9208317 ↗InjuryOct 18, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A CLINICIAN USED THE PORCINE XENOGRAFT ALONG WITH PUROS PARTICULATE ALLOGRAFT AND A BIOMEND ABSORBALE COLLAGEN MEMBRANE. THE PATIENT RETURNED AFTER 5 MONTHS FOR IMPLANT PLACEMENT. THE CLINICIAN REPORTED TO BE UNHAPPY WITH THE OUTCOME OF THE BONE AUGMENTATION AND THE IMPLANT WAS UNABLE TO BE PLACED.
Patient problems: Inadequate Osseointegration
MAUDE report 9208314 ↗InjurySep 23, 2019Insufficient Device Problem Information; Insufficient Device Problem Information
THE CLINICIAN REPORTED HAVING ADVERSE EVENTS THAT THEY HAVE NOT SEEN IN THE PAST. THESE ADVERSE EVENTS INCLUDE BONE LOSS, DELAYED HEALING AND INFLAMMATION. IT IS UNKNOWN HOW THE CLINICIAN CIRCUMVENTED THE ISSUES.
Patient problems: Inflammation; No Code Available
MAUDE report 9106059 ↗
Other Collagen Matrix, Inc. products
All Collagen Matrix, Inc. devices →Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page